Yuki Mizuno Selected Research

Yuki Mizuno Research Topics

Disease

13	Neoplasms (Cancer) 04/2024 - 09/2005
4	Wounds and Injuries (Trauma) 02/2024 - 09/2005
4	Acne Vulgaris 05/2012 - 09/2006
2	Liver Diseases (Liver Disease) 09/2023 - 01/2018
2	Infections 01/2022 - 05/2008
2	Melanoma (Melanoma, Malignant) 11/2017 - 07/2010
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2012 - 03/2012
2	Cicatrix (Scar) 05/2012 - 09/2006
2	Blister (Bulla) 07/2007 - 05/2007
2	Skin Ulcer 05/2007 - 09/2005
2	Peeling Skin Syndrome 10/2006 - 06/2006
1	Fibrosarcoma 04/2024
1	Spinal Cord Injuries (Spinal Cord Injury) 02/2024
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Anorectal Malformations 12/2023
1	Holoprosencephaly (Arhinencephaly) 09/2023
1	Inappropriate ADH Syndrome (SIADH) 09/2023
1	Hyponatremia 09/2023
1	Hypernatremia 09/2023
1	Diabetes Insipidus 09/2023
1	Inguinal Hernia (Direct Inguinal Hernia) 06/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022
1	Leukocyte adhesion deficiency type 1 01/2022
1	Lactic Acidosis 01/2022
1	Velopharyngeal Insufficiency 01/2022
1	Atrophy 01/2022
1	Hyperglycemia 01/2022
1	Cerebral Hemorrhage 01/2022
1	Tracheal Stenosis 08/2021
1	Intellectual Disability (Idiocy) 08/2021
1	Inflammation (Inflammations) 03/2021
1	Infertility (Sterility) 01/2021
1	Pancreatitis 01/2021
1	Body Weight (Weight, Body) 03/2018
1	Insulin Resistance 03/2018
1	Obesity 03/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Carcinogenesis 01/2018
1	Starvation 01/2018
1	Uveitis 11/2017
1	Anterior Uveitis 11/2017
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 05/2015

Drug/Important Bio-Agent (IBA)

7	LigandsIBA 01/2024 - 04/2016
3	IntegrinsIBA 11/2021 - 08/2019
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 03/2018
2	Peptides (Polypeptides)IBA 01/2022 - 11/2021
2	LeptinIBA 03/2018 - 03/2015
1	imidazole ketone erastinIBA 04/2024
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2024
1	Glutathione (Reduced Glutathione)IBA 04/2024
1	Buthionine SulfoximineIBA 04/2024
1	3- carbamoyl- 2,2,5,5- tetramethyl- 1- pyrrolidinyl- N- oxylIBA 04/2024
1	RutheniumIBA 01/2024
1	MetalsIBA 12/2023
1	CollagenIBA 12/2023
1	Tolvaptan FDA Link 09/2023
1	Vasopressins (Vasopressin)IBA 09/2023
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 09/2023
1	SodiumIBA 09/2023
1	Linezolid (Zyvox)FDA Link 01/2022
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	CoagulaseIBA 01/2022
1	arginine thiazolidinecarboxylate (ATCA)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2021
1	Diclofenac (SR 38)FDA LinkGeneric 01/2021
1	EndotoxinsIBA 01/2021
1	hexanoic acid (hexanoate)IBA 01/2020
1	Sunitinib (Sutent)FDA Link 06/2018
1	Therapeutic UsesIBA 03/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2018
1	Insulin (Novolin)FDA Link 03/2018
1	Ethanol (Ethyl Alcohol)IBA 03/2018
1	EmulsionsIBA 03/2018
1	CytokinesIBA 03/2018
1	Olive OilIBA 03/2018
1	Branched-Chain Amino AcidsIBA 01/2018
1	Schiff Bases (Schiff Base)IBA 01/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Immune Checkpoint InhibitorsIBA 11/2017
1	Programmed Cell Death 1 ReceptorIBA 11/2017
1	NivolumabIBA 11/2017
1	Prednisolone (Predate)FDA LinkGeneric 05/2015
1	Conditioned Culture MediaIBA 03/2015

Therapy/Procedure

7	Therapeutics 01/2022 - 05/2007
4	Lasers (Laser) 05/2012 - 09/2006
2	Photochemotherapy (Photodynamic Therapy) 06/2012 - 07/2010
2	Skin Transplantation (Skin Grafting) 01/2007 - 09/2005
1	Intravenous Administration 02/2024
1	Surgical Instruments (Clip) 02/2024
1	Drug Therapy (Chemotherapy) 09/2023
1	Endoscopes 06/2023
1	Transplantation 01/2022
1	Catheters 01/2022
1	Stem Cell Transplantation 01/2022
1	Sternotomy 08/2021
1	Thoracoplasty 08/2021